

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 8.68437741 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 8.68437741 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 8.51667714 |
| 4 | exocrine pancreas development (GO:0031017) | 8.35611756 |
| 5 | protein retention in ER lumen (GO:0006621) | 7.97516029 |
| 6 | endocrine pancreas development (GO:0031018) | 6.70972078 |
| 7 | protein maturation by protein folding (GO:0022417) | 6.34468688 |
| 8 | intestinal cholesterol absorption (GO:0030299) | 6.02589846 |
| 9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.32277096 |
| 10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.29207032 |
| 11 | COPII vesicle coating (GO:0048208) | 5.25500923 |
| 12 | digestion (GO:0007586) | 5.21286764 |
| 13 | glandular epithelial cell differentiation (GO:0002067) | 5.20850315 |
| 14 | positive regulation of nuclease activity (GO:0032075) | 5.05009555 |
| 15 | peptide hormone processing (GO:0016486) | 4.72652381 |
| 16 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.72027732 |
| 17 | regulation of nuclease activity (GO:0032069) | 4.58640352 |
| 18 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.54717597 |
| 19 | cellular response to unfolded protein (GO:0034620) | 4.48093756 |
| 20 | lymphangiogenesis (GO:0001946) | 4.45796943 |
| 21 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.45625354 |
| 22 | type B pancreatic cell development (GO:0003323) | 4.42602797 |
| 23 | cellular response to topologically incorrect protein (GO:0035967) | 4.30461289 |
| 24 | blood vessel maturation (GO:0001955) | 4.24338970 |
| 25 | ER overload response (GO:0006983) | 4.23175844 |
| 26 | ER-nucleus signaling pathway (GO:0006984) | 4.23029137 |
| 27 | signal peptide processing (GO:0006465) | 4.17577245 |
| 28 | glandular epithelial cell development (GO:0002068) | 4.11168839 |
| 29 | inner ear receptor cell development (GO:0060119) | 4.10645369 |
| 30 | insulin secretion (GO:0030073) | 4.10300657 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 4.09133073 |
| 32 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.06054689 |
| 33 | positive regulation of insulin secretion (GO:0032024) | 4.05293833 |
| 34 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.03938200 |
| 35 | regulation of cardioblast proliferation (GO:0003264) | 4.03938200 |
| 36 | intestinal absorption (GO:0050892) | 3.96612552 |
| 37 | embryonic heart tube development (GO:0035050) | 3.95749009 |
| 38 | response to endoplasmic reticulum stress (GO:0034976) | 3.89533933 |
| 39 | pancreas development (GO:0031016) | 3.87742674 |
| 40 | sequestering of metal ion (GO:0051238) | 3.86904949 |
| 41 | vesicle coating (GO:0006901) | 3.82277771 |
| 42 | intestinal epithelial cell development (GO:0060576) | 3.79592914 |
| 43 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.78407522 |
| 44 | glycerophospholipid catabolic process (GO:0046475) | 3.75651466 |
| 45 | positive regulation of gluconeogenesis (GO:0045722) | 3.73740774 |
| 46 | positive regulation of calcium ion import (GO:0090280) | 3.70832640 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.68619398 |
| 48 | regulation of insulin secretion (GO:0050796) | 3.67706094 |
| 49 | nephron tubule morphogenesis (GO:0072078) | 3.62592412 |
| 50 | nephron epithelium morphogenesis (GO:0072088) | 3.62592412 |
| 51 | response to unfolded protein (GO:0006986) | 3.61968513 |
| 52 | left/right pattern formation (GO:0060972) | 3.58395443 |
| 53 | ketone body metabolic process (GO:1902224) | 3.56994176 |
| 54 | response to topologically incorrect protein (GO:0035966) | 3.49099797 |
| 55 | proline biosynthetic process (GO:0006561) | 3.45114240 |
| 56 | inositol phosphate catabolic process (GO:0071545) | 3.43860740 |
| 57 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 3.43710587 |
| 58 | auditory receptor cell differentiation (GO:0042491) | 3.42748222 |
| 59 | maintenance of protein localization in organelle (GO:0072595) | 3.41048959 |
| 60 | morphogenesis of an endothelium (GO:0003159) | 3.37132344 |
| 61 | endothelial tube morphogenesis (GO:0061154) | 3.37132344 |
| 62 | protein localization to Golgi apparatus (GO:0034067) | 3.36216588 |
| 63 | negative regulation of inclusion body assembly (GO:0090084) | 3.35153698 |
| 64 | regulation of peptide hormone secretion (GO:0090276) | 3.33311737 |
| 65 | L-ascorbic acid metabolic process (GO:0019852) | 3.33250153 |
| 66 | inositol phosphate dephosphorylation (GO:0046855) | 3.32928368 |
| 67 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.32928368 |
| 68 | negative regulation of norepinephrine secretion (GO:0010700) | 3.31811884 |
| 69 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.31721306 |
| 70 | glycolipid catabolic process (GO:0019377) | 3.30223640 |
| 71 | nucleoside diphosphate catabolic process (GO:0009134) | 3.29828752 |
| 72 | regulation of peptide secretion (GO:0002791) | 3.27651870 |
| 73 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.27330791 |
| 74 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.26058140 |
| 75 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.25604213 |
| 76 | peptidyl-asparagine modification (GO:0018196) | 3.25396067 |
| 77 | kidney morphogenesis (GO:0060993) | 3.23151196 |
| 78 | cerebellar Purkinje cell layer development (GO:0021680) | 3.21544431 |
| 79 | negative regulation of protein autophosphorylation (GO:0031953) | 3.21501058 |
| 80 | endothelium development (GO:0003158) | 3.21455348 |
| 81 | protein localization to cilium (GO:0061512) | 3.20812825 |
| 82 | negative regulation of insulin secretion (GO:0046676) | 3.19979429 |
| 83 | positive regulation of peptide hormone secretion (GO:0090277) | 3.19780677 |
| 84 | renal tubule morphogenesis (GO:0061333) | 3.19501503 |
| 85 | potassium ion export (GO:0071435) | 3.19297165 |
| 86 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.17281408 |
| 87 | negative regulation of catecholamine secretion (GO:0033604) | 3.17252701 |
| 88 | epithelial cell fate commitment (GO:0072148) | 3.15683671 |
| 89 | GDP-mannose metabolic process (GO:0019673) | 3.13875902 |
| 90 | negative regulation of digestive system process (GO:0060457) | 3.12002586 |
| 91 | regulation of calcium ion import (GO:0090279) | 3.11892688 |
| 92 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.11508638 |
| 93 | mitotic cell cycle arrest (GO:0071850) | 3.11506346 |
| 94 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.11309173 |
| 95 | astrocyte differentiation (GO:0048708) | 3.11197171 |
| 96 | positive regulation of peptide secretion (GO:0002793) | 3.09964111 |
| 97 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.06489961 |
| 98 | heme transport (GO:0015886) | 3.06253133 |
| 99 | transcytosis (GO:0045056) | 3.01772443 |
| 100 | peptide hormone secretion (GO:0030072) | 3.01694102 |
| 101 | positive regulation of glomerulus development (GO:0090193) | 2.99583699 |
| 102 | pharyngeal system development (GO:0060037) | 2.99496471 |
| 103 | detection of calcium ion (GO:0005513) | 2.99084476 |
| 104 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.98238534 |
| 105 | endothelial cell chemotaxis (GO:0035767) | 2.98152727 |
| 106 | protein N-linked glycosylation (GO:0006487) | 2.97920438 |
| 107 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.97636655 |
| 108 | regulation of endothelial cell differentiation (GO:0045601) | 2.97208044 |
| 109 | neuron fate determination (GO:0048664) | 2.95347727 |
| 110 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.95275567 |
| 111 | response to hepatocyte growth factor (GO:0035728) | 2.95275567 |
| 112 | mRNA transcription (GO:0009299) | 2.95032296 |
| 113 | ceramide catabolic process (GO:0046514) | 2.94698301 |
| 114 | peptide secretion (GO:0002790) | 2.93908248 |
| 115 | response to hexose (GO:0009746) | 2.92963500 |
| 116 | intraciliary transport (GO:0042073) | 2.86885135 |
| 117 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.86477369 |
| 118 | polyol catabolic process (GO:0046174) | 2.86248674 |
| 119 | regulation of hormone secretion (GO:0046883) | 2.85737459 |
| 120 | response to glucose (GO:0009749) | 2.84925058 |
| 121 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.84745223 |
| 122 | nitric oxide mediated signal transduction (GO:0007263) | 2.84043737 |
| 123 | chemosensory behavior (GO:0007635) | 2.83092779 |
| 124 | regulation of hexokinase activity (GO:1903299) | 2.83059582 |
| 125 | regulation of glucokinase activity (GO:0033131) | 2.83059582 |
| 126 | alanine transport (GO:0032328) | 2.82768857 |
| 127 | 4-hydroxyproline metabolic process (GO:0019471) | 2.82141967 |
| 128 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.82018150 |
| 129 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.82006932 |
| 130 | positive regulation of receptor internalization (GO:0002092) | 2.81341478 |
| 131 | zinc ion transport (GO:0006829) | 2.80874699 |
| 132 | Golgi organization (GO:0007030) | 2.78444726 |
| 133 | neuron fate specification (GO:0048665) | 2.77771287 |
| 134 | peptidyl-proline hydroxylation (GO:0019511) | 2.76595285 |
| 135 | cellular response to vitamin D (GO:0071305) | 2.76547098 |
| 136 | response to monosaccharide (GO:0034284) | 2.76219332 |
| 137 | protein targeting to Golgi (GO:0000042) | 2.76151185 |
| 138 | negative regulation of peptide hormone secretion (GO:0090278) | 2.75530001 |
| 139 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.75415250 |
| 140 | zinc ion homeostasis (GO:0055069) | 2.68208036 |
| 141 | cellular response to hexose stimulus (GO:0071331) | 2.67391758 |
| 142 | cobalamin metabolic process (GO:0009235) | 2.66977988 |
| 143 | regulation of extracellular matrix disassembly (GO:0010715) | 2.66806903 |
| 144 | negative regulation of peptide secretion (GO:0002792) | 2.66106727 |
| 145 | regulation of glucocorticoid secretion (GO:2000849) | 2.65923677 |
| 146 | nitric oxide biosynthetic process (GO:0006809) | 2.64438409 |
| 147 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.63645062 |
| 148 | iron coordination entity transport (GO:1901678) | 2.61706664 |
| 149 | regulation of acrosome reaction (GO:0060046) | 2.60619663 |
| 150 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.59614747 |
| 151 | ovulation from ovarian follicle (GO:0001542) | 2.58470127 |
| 152 | regulation of inclusion body assembly (GO:0090083) | 2.55999625 |
| 153 | endothelial cell differentiation (GO:0045446) | 2.54439986 |
| 154 | leukocyte tethering or rolling (GO:0050901) | 2.51440405 |
| 155 | regulation of energy homeostasis (GO:2000505) | 2.51319161 |
| 156 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.51017288 |
| 157 | positive regulation of glycolytic process (GO:0045821) | 2.49470803 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.48768288 |
| 159 | L-phenylalanine catabolic process (GO:0006559) | 2.48768288 |
| 160 | sphingomyelin metabolic process (GO:0006684) | 2.48676311 |
| 161 | dentate gyrus development (GO:0021542) | 2.48529570 |
| 162 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.47281507 |
| 163 | negative regulation of gluconeogenesis (GO:0045721) | 2.44622040 |
| 164 | inositol phosphate-mediated signaling (GO:0048016) | 2.43979549 |
| 165 | cytochrome complex assembly (GO:0017004) | 2.43791914 |
| 166 | macroautophagy (GO:0016236) | 2.43411167 |
| 167 | membrane repolarization during action potential (GO:0086011) | 2.42439513 |
| 168 | cellular response to zinc ion (GO:0071294) | 2.42279197 |
| 169 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.41571767 |
| 170 | cellular zinc ion homeostasis (GO:0006882) | 2.40806013 |
| 171 | vitamin transport (GO:0051180) | 2.40322670 |
| 172 | respiratory chain complex IV assembly (GO:0008535) | 2.36674530 |
| 173 | magnesium ion transport (GO:0015693) | 2.34917910 |
| 174 | L-phenylalanine metabolic process (GO:0006558) | 2.34244866 |
| 175 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34244866 |
| 176 | retinol metabolic process (GO:0042572) | 2.32951989 |
| 177 | urate metabolic process (GO:0046415) | 2.31272475 |
| 178 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.30663757 |
| 179 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.30663757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.68433374 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.76629163 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54250805 |
| 4 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.48313343 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.02835578 |
| 6 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.48972347 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.26580289 |
| 8 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.21141300 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16052350 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98155906 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.93684736 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84517564 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.81499660 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79447470 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.78092602 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77861464 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.77061295 |
| 18 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73485953 |
| 19 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73391039 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68577109 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60167017 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57112688 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50204190 |
| 24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48511934 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48272607 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.46717879 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45960115 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45675272 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45259220 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43889443 |
| 31 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43889053 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43570873 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42604276 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42469893 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42385261 |
| 36 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.41457097 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40772737 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40360733 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.38792654 |
| 40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38240787 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37904021 |
| 42 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36406000 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36358764 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34963782 |
| 45 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34112419 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.32895716 |
| 47 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28422319 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28039400 |
| 49 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27400587 |
| 50 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.24637306 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24477173 |
| 52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24399953 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24345607 |
| 54 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.21671320 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19254783 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19233983 |
| 57 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19113334 |
| 58 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19065170 |
| 59 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18472182 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.18220973 |
| 61 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17272470 |
| 62 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.15209832 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15138912 |
| 64 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14953241 |
| 65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12143658 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11950670 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11795569 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11194077 |
| 69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.11016014 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10579256 |
| 71 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10578698 |
| 72 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.10116981 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09916711 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09287414 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07898106 |
| 76 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07287166 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06301455 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06276727 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06130001 |
| 80 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04659548 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04590614 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04551258 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04386313 |
| 84 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02652563 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02560655 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02500646 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02391426 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01974807 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01884229 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01728195 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01191258 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01089808 |
| 93 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.01088362 |
| 94 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.01088362 |
| 95 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.00660981 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99397960 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99326855 |
| 98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98536519 |
| 99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97861075 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96802100 |
| 101 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96314433 |
| 102 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.96160840 |
| 103 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95970997 |
| 104 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95951860 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95542980 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94998648 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94685684 |
| 108 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94042473 |
| 109 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94042473 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93980950 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93970303 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93889270 |
| 113 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93012508 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92111733 |
| 115 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91741089 |
| 116 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91669403 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91131497 |
| 118 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91002664 |
| 119 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90804722 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90665969 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90577298 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90576115 |
| 123 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90285174 |
| 124 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89365056 |
| 125 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.89225671 |
| 126 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.89044507 |
| 127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.89000981 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88349778 |
| 129 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87902023 |
| 130 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87821431 |
| 131 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87470675 |
| 132 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85866277 |
| 133 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85866277 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85608589 |
| 135 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85543129 |
| 136 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84545086 |
| 137 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.84166546 |
| 138 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84091420 |
| 139 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84085479 |
| 140 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83934496 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83659051 |
| 142 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83480194 |
| 143 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83375292 |
| 144 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83145284 |
| 145 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.82959484 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82925332 |
| 147 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82896776 |
| 148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82693001 |
| 149 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82558706 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82557302 |
| 151 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82446517 |
| 152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81351619 |
| 153 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81288643 |
| 154 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81140382 |
| 155 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79748397 |
| 156 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.79256765 |
| 157 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78452224 |
| 158 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.78340698 |
| 159 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78024514 |
| 160 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77084670 |
| 161 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.76794626 |
| 162 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.76629590 |
| 163 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.75870410 |
| 164 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74024091 |
| 165 | AR_19668381_ChIP-Seq_PC3_Human | 0.73980813 |
| 166 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73628855 |
| 167 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73533723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005220_abnormal_exocrine_pancreas | 4.81804215 |
| 2 | MP0004043_abnormal_pH_regulation | 4.43617966 |
| 3 | MP0002693_abnormal_pancreas_physiology | 4.39792327 |
| 4 | MP0001944_abnormal_pancreas_morphology | 3.76655961 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 3.75946393 |
| 6 | MP0000678_abnormal_parathyroid_gland | 3.75844556 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.52196817 |
| 8 | MP0002909_abnormal_adrenal_gland | 3.47908034 |
| 9 | MP0003283_abnormal_digestive_organ | 3.38623698 |
| 10 | MP0005083_abnormal_biliary_tract | 3.37500039 |
| 11 | MP0005365_abnormal_bile_salt | 2.92354024 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.83215250 |
| 13 | MP0003195_calcinosis | 2.82104452 |
| 14 | MP0002254_reproductive_system_inflammat | 2.78842428 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.77519406 |
| 16 | MP0001879_abnormal_lymphatic_vessel | 2.77458367 |
| 17 | MP0002163_abnormal_gland_morphology | 2.61271900 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.48548868 |
| 19 | MP0010386_abnormal_urinary_bladder | 2.43153385 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.34709554 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.32390098 |
| 22 | MP0003868_abnormal_feces_composition | 2.14246685 |
| 23 | MP0001849_ear_inflammation | 2.14171570 |
| 24 | MP0002078_abnormal_glucose_homeostasis | 2.12438887 |
| 25 | MP0003724_increased_susceptibility_to | 2.11448806 |
| 26 | MP0006072_abnormal_retinal_apoptosis | 2.08379422 |
| 27 | MP0010368_abnormal_lymphatic_system | 2.07685542 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 2.04024730 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.95809674 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.80636018 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.78397735 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.76265896 |
| 33 | MP0002234_abnormal_pharynx_morphology | 1.74652000 |
| 34 | MP0000516_abnormal_urinary_system | 1.73374973 |
| 35 | MP0005367_renal/urinary_system_phenotyp | 1.73374973 |
| 36 | MP0002928_abnormal_bile_duct | 1.67237232 |
| 37 | MP0000003_abnormal_adipose_tissue | 1.65178520 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.61213133 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.56879419 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.54049412 |
| 41 | MP0005409_darkened_coat_color | 1.51084629 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.47617264 |
| 43 | MP0000631_abnormal_neuroendocrine_gland | 1.44157175 |
| 44 | MP0008004_abnormal_stomach_pH | 1.43269734 |
| 45 | MP0003953_abnormal_hormone_level | 1.42930402 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.39791446 |
| 47 | MP0002876_abnormal_thyroid_physiology | 1.38663480 |
| 48 | MP0009840_abnormal_foam_cell | 1.35308582 |
| 49 | MP0004133_heterotaxia | 1.34862597 |
| 50 | MP0003959_abnormal_lean_body | 1.34495400 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.34329107 |
| 52 | MP0003303_peritoneal_inflammation | 1.33477692 |
| 53 | MP0004270_analgesia | 1.32616243 |
| 54 | MP0001664_abnormal_digestion | 1.31504689 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.29971077 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.29591853 |
| 57 | MP0003122_maternal_imprinting | 1.28771781 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.26375021 |
| 59 | MP0009046_muscle_twitch | 1.26299690 |
| 60 | MP0005448_abnormal_energy_balance | 1.25685877 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.25018628 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.24747633 |
| 63 | MP0004147_increased_porphyrin_level | 1.24687528 |
| 64 | MP0005332_abnormal_amino_acid | 1.23319173 |
| 65 | MP0000613_abnormal_salivary_gland | 1.22268720 |
| 66 | MP0000462_abnormal_digestive_system | 1.22154025 |
| 67 | MP0003119_abnormal_digestive_system | 1.19807874 |
| 68 | MP0001270_distended_abdomen | 1.19576193 |
| 69 | MP0003638_abnormal_response/metabolism_ | 1.18974565 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.18114051 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.13447207 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.12561130 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.11322929 |
| 74 | MP0004484_altered_response_of | 1.09554554 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.06742132 |
| 76 | MP0003879_abnormal_hair_cell | 1.06400530 |
| 77 | MP0004215_abnormal_myocardial_fiber | 1.05824148 |
| 78 | MP0005535_abnormal_body_temperature | 1.04566430 |
| 79 | MP0005375_adipose_tissue_phenotype | 1.03351535 |
| 80 | MP0004858_abnormal_nervous_system | 1.02291350 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.02284603 |
| 82 | MP0005187_abnormal_penis_morphology | 0.98911898 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.98644352 |
| 84 | MP0005085_abnormal_gallbladder_physiolo | 0.98581603 |
| 85 | MP0001851_eye_inflammation | 0.98019716 |
| 86 | MP0009745_abnormal_behavioral_response | 0.96925439 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.96431233 |
| 88 | MP0005253_abnormal_eye_physiology | 0.90757293 |
| 89 | MP0000343_altered_response_to | 0.90052792 |
| 90 | MP0003011_delayed_dark_adaptation | 0.88010018 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.87563775 |
| 92 | MP0005408_hypopigmentation | 0.85536954 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.85421209 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.84890224 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 0.84767292 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.84719798 |
| 97 | MP0004885_abnormal_endolymph | 0.84149592 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.83690278 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.83003391 |
| 100 | MP0002139_abnormal_hepatobiliary_system | 0.82983079 |
| 101 | MP0000049_abnormal_middle_ear | 0.80979917 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.80668642 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 0.80609564 |
| 104 | MP0003045_fibrosis | 0.80410215 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.79934663 |
| 106 | MP0004085_abnormal_heartbeat | 0.79594906 |
| 107 | MP0003787_abnormal_imprinting | 0.79575680 |
| 108 | MP0003633_abnormal_nervous_system | 0.78293451 |
| 109 | MP0004859_abnormal_synaptic_plasticity | 0.77713308 |
| 110 | MP0006292_abnormal_olfactory_placode | 0.75451619 |
| 111 | MP0005389_reproductive_system_phenotype | 0.75042771 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.74594488 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.74581238 |
| 114 | MP0002177_abnormal_outer_ear | 0.74100636 |
| 115 | MP0001764_abnormal_homeostasis | 0.73476030 |
| 116 | MP0003075_altered_response_to | 0.72877874 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.72228790 |
| 118 | MP0004510_myositis | 0.71342882 |
| 119 | MP0002064_seizures | 0.70059534 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.67614661 |
| 121 | MP0001177_atelectasis | 0.67587589 |
| 122 | MP0003279_aneurysm | 0.64509794 |
| 123 | MP0000465_gastrointestinal_hemorrhage | 0.64386070 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.63432442 |
| 125 | MP0003252_abnormal_bile_duct | 0.62704289 |
| 126 | MP0001905_abnormal_dopamine_level | 0.62664928 |
| 127 | MP0001756_abnormal_urination | 0.62009846 |
| 128 | MP0002751_abnormal_autonomic_nervous | 0.61616252 |
| 129 | MP0003329_amyloid_beta_deposits | 0.61315218 |
| 130 | MP0006054_spinal_hemorrhage | 0.61118783 |
| 131 | MP0005334_abnormal_fat_pad | 0.60926492 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.60184268 |
| 133 | MP0003635_abnormal_synaptic_transmissio | 0.59954953 |
| 134 | MP0000955_abnormal_spinal_cord | 0.59702874 |
| 135 | MP0003186_abnormal_redox_activity | 0.59408351 |
| 136 | MP0002971_abnormal_brown_adipose | 0.58624617 |
| 137 | MP0002733_abnormal_thermal_nociception | 0.58593146 |
| 138 | MP0000470_abnormal_stomach_morphology | 0.56216600 |
| 139 | MP0002098_abnormal_vibrissa_morphology | 0.56070176 |
| 140 | MP0005166_decreased_susceptibility_to | 0.55849574 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.55446546 |
| 142 | MP0002160_abnormal_reproductive_system | 0.54574106 |
| 143 | MP0005310_abnormal_salivary_gland | 0.53400283 |
| 144 | MP0002090_abnormal_vision | 0.52817529 |
| 145 | MP0005670_abnormal_white_adipose | 0.52678157 |
| 146 | MP0009672_abnormal_birth_weight | 0.52327023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 7.12040932 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.02010523 |
| 3 | Symptomatic seizures (HP:0011145) | 6.34108170 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.42912012 |
| 5 | Hypoglycemic coma (HP:0001325) | 5.30387673 |
| 6 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.54274849 |
| 7 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.54274849 |
| 8 | Hemiparesis (HP:0001269) | 4.49383939 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.48735756 |
| 10 | Ketoacidosis (HP:0001993) | 4.44817482 |
| 11 | Hyperglycemia (HP:0003074) | 4.37070622 |
| 12 | Vascular calcification (HP:0004934) | 4.19061443 |
| 13 | Large for gestational age (HP:0001520) | 4.15117176 |
| 14 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.01790572 |
| 15 | Late onset (HP:0003584) | 3.95362569 |
| 16 | Decreased circulating renin level (HP:0003351) | 3.89554889 |
| 17 | Hyperkalemia (HP:0002153) | 3.85950954 |
| 18 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.77428764 |
| 19 | Cardiovascular calcification (HP:0011915) | 3.66314690 |
| 20 | Hypothermia (HP:0002045) | 3.64352854 |
| 21 | Hematochezia (HP:0002573) | 3.63895619 |
| 22 | Abnormal pancreas size (HP:0012094) | 3.56920221 |
| 23 | Polydipsia (HP:0001959) | 3.46830971 |
| 24 | Abnormal drinking behavior (HP:0030082) | 3.46830971 |
| 25 | Tubulointerstitial nephritis (HP:0001970) | 3.42770053 |
| 26 | Gout (HP:0001997) | 3.35342862 |
| 27 | Abnormality of vitamin B metabolism (HP:0004340) | 3.19757760 |
| 28 | Congenital stationary night blindness (HP:0007642) | 3.16835676 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.09959935 |
| 30 | Increased CSF protein (HP:0002922) | 3.09190678 |
| 31 | Tubular atrophy (HP:0000092) | 3.03348188 |
| 32 | Abnormality of potassium homeostasis (HP:0011042) | 3.02845385 |
| 33 | Hypokalemia (HP:0002900) | 3.01646604 |
| 34 | Congenital, generalized hypertrichosis (HP:0004540) | 3.01612397 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01496760 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99310632 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.99310632 |
| 38 | Lymphangioma (HP:0100764) | 2.95683615 |
| 39 | Chronic bronchitis (HP:0004469) | 2.90569133 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.87965596 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.86298089 |
| 42 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.85136914 |
| 43 | Lip pit (HP:0100267) | 2.82023181 |
| 44 | Insulin resistance (HP:0000855) | 2.80692847 |
| 45 | Unilateral renal agenesis (HP:0000122) | 2.79365792 |
| 46 | Ketosis (HP:0001946) | 2.74884283 |
| 47 | Renal salt wasting (HP:0000127) | 2.70192989 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.68320014 |
| 49 | Enlarged penis (HP:0000040) | 2.67723778 |
| 50 | Double outlet right ventricle (HP:0001719) | 2.67708386 |
| 51 | Congenital malformation of the right heart (HP:0011723) | 2.67708386 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66443462 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66443462 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66443462 |
| 55 | Abnormality of vitamin metabolism (HP:0100508) | 2.65211908 |
| 56 | Absent eyebrow (HP:0002223) | 2.62641664 |
| 57 | Hypokalemic alkalosis (HP:0001949) | 2.60694306 |
| 58 | Hyperphosphatemia (HP:0002905) | 2.59148125 |
| 59 | Tongue fasciculations (HP:0001308) | 2.57880731 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.57831312 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55199863 |
| 62 | Agitation (HP:0000713) | 2.53909956 |
| 63 | Exocrine pancreatic insufficiency (HP:0001738) | 2.53586917 |
| 64 | Abnormality of renin-angiotensin system (HP:0000847) | 2.53261646 |
| 65 | Intestinal atresia (HP:0011100) | 2.50486294 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 2.50247195 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.48969427 |
| 68 | Osteomalacia (HP:0002749) | 2.46407373 |
| 69 | Abnormality of chloride homeostasis (HP:0011422) | 2.44660159 |
| 70 | Epileptiform EEG discharges (HP:0011182) | 2.42669537 |
| 71 | Pancreatic fibrosis (HP:0100732) | 2.40266240 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39282105 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.38628016 |
| 74 | Congenital glaucoma (HP:0001087) | 2.37964707 |
| 75 | Retinal atrophy (HP:0001105) | 2.35625569 |
| 76 | Muscle fibrillation (HP:0010546) | 2.34992348 |
| 77 | Stenosis of the external auditory canal (HP:0000402) | 2.33460711 |
| 78 | Polyuria (HP:0000103) | 2.32007976 |
| 79 | Maternal diabetes (HP:0009800) | 2.31930383 |
| 80 | Pancreatic cysts (HP:0001737) | 2.31255230 |
| 81 | Prominent metopic ridge (HP:0005487) | 2.29719662 |
| 82 | Hyperthyroidism (HP:0000836) | 2.28241461 |
| 83 | Visual hallucinations (HP:0002367) | 2.26211565 |
| 84 | Chronic hepatic failure (HP:0100626) | 2.25935697 |
| 85 | Cortical visual impairment (HP:0100704) | 2.25530967 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 2.24493961 |
| 87 | Syncope (HP:0001279) | 2.22990083 |
| 88 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21623723 |
| 89 | Diplopia (HP:0000651) | 2.18377267 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.18377267 |
| 91 | Prolonged QT interval (HP:0001657) | 2.17123249 |
| 92 | Hypotension (HP:0002615) | 2.16895493 |
| 93 | Enlarged kidneys (HP:0000105) | 2.15537567 |
| 94 | Hyperaldosteronism (HP:0000859) | 2.15126257 |
| 95 | Hypoplasia of the uterus (HP:0000013) | 2.14825542 |
| 96 | Renal cortical cysts (HP:0000803) | 2.13419459 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 2.13328572 |
| 98 | Glycosuria (HP:0003076) | 2.13328572 |
| 99 | Facial shape deformation (HP:0011334) | 2.13312808 |
| 100 | Potter facies (HP:0002009) | 2.13312808 |
| 101 | Episodic fever (HP:0001954) | 2.13145246 |
| 102 | Xanthomatosis (HP:0000991) | 2.12435506 |
| 103 | Chronic sinusitis (HP:0011109) | 2.12340383 |
| 104 | Type I diabetes mellitus (HP:0100651) | 2.12312803 |
| 105 | Tetraparesis (HP:0002273) | 2.11747645 |
| 106 | Absence seizures (HP:0002121) | 2.11273907 |
| 107 | Hydroureter (HP:0000072) | 2.11258821 |
| 108 | Tubulointerstitial abnormality (HP:0001969) | 2.10312707 |
| 109 | Adrenal overactivity (HP:0002717) | 2.09880532 |
| 110 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09111469 |
| 111 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09111469 |
| 112 | Abnormal protein glycosylation (HP:0012346) | 2.09111469 |
| 113 | Abnormal glycosylation (HP:0012345) | 2.09111469 |
| 114 | Nonimmune hydrops fetalis (HP:0001790) | 2.06091965 |
| 115 | Abnormality of magnesium homeostasis (HP:0004921) | 2.05061540 |
| 116 | Hypercortisolism (HP:0001578) | 2.04634807 |
| 117 | Ventricular fibrillation (HP:0001663) | 2.03343867 |
| 118 | Decreased subcutaneous fat (HP:0001002) | 2.02986543 |
| 119 | Abnormal urine output (HP:0012590) | 2.00797715 |
| 120 | Methylmalonic acidemia (HP:0002912) | 1.98926383 |
| 121 | Hypomagnesemia (HP:0002917) | 1.97846245 |
| 122 | Abnormal biliary tract morphology (HP:0012440) | 1.97806451 |
| 123 | Cystic liver disease (HP:0006706) | 1.97473249 |
| 124 | Hypokinesia (HP:0002375) | 1.96963637 |
| 125 | Dysautonomia (HP:0002459) | 1.95859285 |
| 126 | Urethral obstruction (HP:0000796) | 1.95427420 |
| 127 | Hypotrichosis (HP:0001006) | 1.95075415 |
| 128 | Methylmalonic aciduria (HP:0012120) | 1.94785348 |
| 129 | Abdominal distention (HP:0003270) | 1.91712989 |
| 130 | Decreased central vision (HP:0007663) | 1.91172795 |
| 131 | Testicular neoplasm (HP:0010788) | 1.90483780 |
| 132 | Popliteal pterygium (HP:0009756) | 1.90262792 |
| 133 | Hypoplasia of the fovea (HP:0007750) | 1.89518631 |
| 134 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.89518631 |
| 135 | Abnormal EKG (HP:0003115) | 1.87867455 |
| 136 | Increased circulating renin level (HP:0000848) | 1.86351733 |
| 137 | Postural tremor (HP:0002174) | 1.85226949 |
| 138 | Generalized aminoaciduria (HP:0002909) | 1.84730285 |
| 139 | Villous atrophy (HP:0011473) | 1.84692603 |
| 140 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.84692603 |
| 141 | Dialeptic seizures (HP:0011146) | 1.83638574 |
| 142 | Tubulointerstitial fibrosis (HP:0005576) | 1.83628793 |
| 143 | Abnormality of the metopic suture (HP:0005556) | 1.83526794 |
| 144 | Bone cyst (HP:0012062) | 1.82594696 |
| 145 | Abnormal sex determination (HP:0012244) | 1.81180303 |
| 146 | Sex reversal (HP:0012245) | 1.81180303 |
| 147 | Confusion (HP:0001289) | 1.81121576 |
| 148 | Type II diabetes mellitus (HP:0005978) | 1.80935546 |
| 149 | Mixed hearing impairment (HP:0000410) | 1.80683846 |
| 150 | Palpebral edema (HP:0100540) | 1.80604671 |
| 151 | Metaphyseal dysplasia (HP:0100255) | 1.80271896 |
| 152 | Alkalosis (HP:0001948) | 1.79801897 |
| 153 | Progressive macrocephaly (HP:0004481) | 1.79525077 |
| 154 | Abnormality of purine metabolism (HP:0004352) | 1.79207041 |
| 155 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.78935473 |
| 156 | Abnormality of the renal medulla (HP:0100957) | 1.77907885 |
| 157 | Hyponatremia (HP:0002902) | 1.76941610 |
| 158 | Abnormality of renal excretion (HP:0011036) | 1.75503440 |
| 159 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74363062 |
| 160 | Morphological abnormality of the middle ear (HP:0008609) | 1.72352385 |
| 161 | Abnormality of the common coagulation pathway (HP:0010990) | 1.71831788 |
| 162 | Renal dysplasia (HP:0000110) | 1.71534565 |
| 163 | Bronchitis (HP:0012387) | 1.71236307 |
| 164 | Tachypnea (HP:0002789) | 1.70208972 |
| 165 | Turricephaly (HP:0000262) | 1.69406971 |
| 166 | Fat malabsorption (HP:0002630) | 1.67876061 |
| 167 | Deep palmar crease (HP:0006191) | 1.66871685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.03747279 |
| 2 | INSRR | 5.97478948 |
| 3 | MAPK15 | 5.82894821 |
| 4 | TSSK6 | 4.89088298 |
| 5 | PASK | 4.31343273 |
| 6 | ERN1 | 3.36466574 |
| 7 | PRKD3 | 3.23514039 |
| 8 | WNK4 | 3.20933747 |
| 9 | MAP3K2 | 3.07867781 |
| 10 | GRK1 | 3.07431750 |
| 11 | TAOK3 | 2.82156252 |
| 12 | HIPK2 | 2.45621909 |
| 13 | NTRK3 | 2.45061065 |
| 14 | BCKDK | 2.18108413 |
| 15 | DAPK2 | 2.14481021 |
| 16 | MAP4K2 | 2.14026154 |
| 17 | MST4 | 2.08625800 |
| 18 | CAMKK2 | 2.03282044 |
| 19 | FGFR2 | 1.82617170 |
| 20 | FER | 1.77443127 |
| 21 | PHKG2 | 1.77003701 |
| 22 | PHKG1 | 1.77003701 |
| 23 | MAP3K1 | 1.66801310 |
| 24 | IRAK3 | 1.61655073 |
| 25 | PINK1 | 1.61473712 |
| 26 | EIF2AK3 | 1.58551024 |
| 27 | FLT3 | 1.58268150 |
| 28 | MAP2K2 | 1.55289164 |
| 29 | TRIB3 | 1.54101885 |
| 30 | PTK6 | 1.51712399 |
| 31 | BCR | 1.49621609 |
| 32 | NTRK1 | 1.48502644 |
| 33 | ADRBK2 | 1.47288057 |
| 34 | EPHA3 | 1.46981019 |
| 35 | FRK | 1.45942575 |
| 36 | TRPM7 | 1.45298611 |
| 37 | CDC42BPA | 1.39438552 |
| 38 | STK24 | 1.38352544 |
| 39 | FGFR3 | 1.37692747 |
| 40 | NME1 | 1.37334455 |
| 41 | PTK2 | 1.35658543 |
| 42 | MAPKAPK3 | 1.34443724 |
| 43 | OXSR1 | 1.31153504 |
| 44 | BMPR1B | 1.23848996 |
| 45 | STK3 | 1.16562864 |
| 46 | CAMKK1 | 1.15333699 |
| 47 | MARK2 | 1.14533478 |
| 48 | IRAK1 | 1.12036660 |
| 49 | WNK3 | 1.11847490 |
| 50 | PAK3 | 1.09613856 |
| 51 | UHMK1 | 1.07770648 |
| 52 | PDGFRA | 1.03687811 |
| 53 | PRKD2 | 1.01989817 |
| 54 | EPHB2 | 0.99993587 |
| 55 | PDGFRB | 0.99518357 |
| 56 | EPHA2 | 0.98261633 |
| 57 | SIK1 | 0.95417081 |
| 58 | STK38L | 0.88665666 |
| 59 | TAOK1 | 0.87701641 |
| 60 | TESK1 | 0.85025550 |
| 61 | MAP3K4 | 0.84454321 |
| 62 | PRKCH | 0.81705867 |
| 63 | CSNK1G1 | 0.80523266 |
| 64 | TEC | 0.77981978 |
| 65 | CDK12 | 0.76938718 |
| 66 | TLK1 | 0.74713927 |
| 67 | DYRK1B | 0.74065882 |
| 68 | CAMK1G | 0.73563773 |
| 69 | PRKCI | 0.73118717 |
| 70 | EPHB1 | 0.72206089 |
| 71 | PRKCE | 0.70922383 |
| 72 | RPS6KA5 | 0.69139891 |
| 73 | SCYL2 | 0.68527008 |
| 74 | IKBKB | 0.67316993 |
| 75 | RIPK4 | 0.66897883 |
| 76 | MAP3K3 | 0.65579131 |
| 77 | MET | 0.64734847 |
| 78 | TBK1 | 0.64349709 |
| 79 | CDK3 | 0.63472291 |
| 80 | RIPK1 | 0.63260415 |
| 81 | WNK1 | 0.63088037 |
| 82 | ZAP70 | 0.61720446 |
| 83 | MAP3K7 | 0.61332877 |
| 84 | PRKAA2 | 0.61330081 |
| 85 | TNK2 | 0.61060737 |
| 86 | ITK | 0.60635634 |
| 87 | CAMK2B | 0.60569804 |
| 88 | PIK3CG | 0.60323642 |
| 89 | CAMK2D | 0.59926360 |
| 90 | NLK | 0.59819111 |
| 91 | BRSK2 | 0.56441855 |
| 92 | PRKCQ | 0.55278778 |
| 93 | VRK1 | 0.53906777 |
| 94 | CAMK1 | 0.52583860 |
| 95 | MAP3K9 | 0.52446820 |
| 96 | RET | 0.51472163 |
| 97 | KDR | 0.50815353 |
| 98 | GSK3A | 0.50521100 |
| 99 | MAP3K12 | 0.50226749 |
| 100 | IRAK2 | 0.49269066 |
| 101 | PRKD1 | 0.48319860 |
| 102 | NEK6 | 0.47760654 |
| 103 | ABL2 | 0.47589586 |
| 104 | MAP3K14 | 0.46428812 |
| 105 | MAP2K6 | 0.46036031 |
| 106 | MAP2K1 | 0.44371091 |
| 107 | AKT3 | 0.43207529 |
| 108 | KSR2 | 0.43011766 |
| 109 | IKBKE | 0.42739951 |
| 110 | STK11 | 0.42538976 |
| 111 | DDR2 | 0.40578888 |
| 112 | DYRK1A | 0.37939480 |
| 113 | EPHA4 | 0.37383820 |
| 114 | PRKCG | 0.36795000 |
| 115 | PTK2B | 0.36600837 |
| 116 | MARK3 | 0.35200901 |
| 117 | CASK | 0.35011894 |
| 118 | PIK3CA | 0.34582688 |
| 119 | OBSCN | 0.34346410 |
| 120 | MYLK | 0.34188636 |
| 121 | IRAK4 | 0.34132086 |
| 122 | CSNK1A1L | 0.34090390 |
| 123 | STK4 | 0.33918721 |
| 124 | CSNK1G2 | 0.33103701 |
| 125 | PRKACA | 0.32553499 |
| 126 | CDK5 | 0.32013370 |
| 127 | BRAF | 0.31816787 |
| 128 | CAMK2A | 0.31584534 |
| 129 | RPS6KA2 | 0.31316413 |
| 130 | IGF1R | 0.30853240 |
| 131 | ACVR1B | 0.30556356 |
| 132 | PKN2 | 0.30438232 |
| 133 | STK39 | 0.30406279 |
| 134 | ERBB3 | 0.28178506 |
| 135 | MTOR | 0.26969290 |
| 136 | CHUK | 0.26595609 |
| 137 | CSNK1G3 | 0.25977439 |
| 138 | FGFR4 | 0.25595910 |
| 139 | BMPR2 | 0.25573761 |
| 140 | PRKACB | 0.24431931 |
| 141 | SGK1 | 0.23971410 |
| 142 | JAK2 | 0.23683150 |
| 143 | CSNK1A1 | 0.23647397 |
| 144 | EGFR | 0.23601293 |
| 145 | PRKACG | 0.23293629 |
| 146 | PNCK | 0.22118949 |
| 147 | PRKAA1 | 0.21727850 |
| 148 | ADRBK1 | 0.20988511 |
| 149 | STK38 | 0.20954893 |
| 150 | PDPK1 | 0.19996070 |
| 151 | GRK5 | 0.19780926 |
| 152 | PRKCA | 0.19029037 |
| 153 | RPS6KA3 | 0.18662438 |
| 154 | RPS6KB1 | 0.18528605 |
| 155 | ERBB2 | 0.17688996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.38060381 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.71278507 |
| 3 | Pancreatic secretion_Homo sapiens_hsa04972 | 3.78352574 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.09860136 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 3.08886739 |
| 6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.20044307 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15822136 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.07065508 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.05626624 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.04423552 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.01960297 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99872731 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83318762 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77490872 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69712623 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66779949 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.62061244 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.59908349 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.58567628 |
| 20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.52468626 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45667150 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41920956 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41230716 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.40426010 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31586047 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29256512 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27518103 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25314580 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.21686921 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.15347352 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14620295 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09498807 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09171250 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09080994 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.07161467 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04665864 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04205082 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04162716 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96519735 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 0.95265857 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93635621 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93343408 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93338479 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93324585 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 0.91850078 |
| 46 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.91824601 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88756289 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88596350 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86967309 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84639515 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84373083 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.81981840 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80392416 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80163237 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78979962 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78093079 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78088528 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77192969 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.76587636 |
| 60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76562129 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75041585 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73978141 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72703127 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71789947 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70073131 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.69468232 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69460254 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69425330 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68734950 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68644421 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.67536040 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65863210 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62837749 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60336599 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.59811305 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59810036 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59664581 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59314672 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58726380 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58463941 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57818120 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57190254 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.56646616 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.56191971 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55544107 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54890906 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53257905 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53038153 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52600151 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52259582 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52007171 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51028851 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50187030 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.50082709 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49340023 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48941985 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46008217 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45373870 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45062608 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44381575 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44096048 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43319500 |
| 103 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43248009 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43079490 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.42905274 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42579424 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40960729 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40940072 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40317094 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.39934734 |
| 111 | Salivary secretion_Homo sapiens_hsa04970 | 0.38641688 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38513215 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.38464722 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38247958 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37242761 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37206521 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36797651 |
| 118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33594555 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33180183 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31849516 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30201687 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29398310 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.28963469 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.28640144 |
| 125 | Nicotine addiction_Homo sapiens_hsa05033 | 0.27460852 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26723254 |
| 127 | Long-term depression_Homo sapiens_hsa04730 | 0.26111808 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25626205 |
| 129 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25498465 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25205076 |
| 131 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24640198 |
| 132 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.22740813 |
| 133 | Gap junction_Homo sapiens_hsa04540 | 0.22710783 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22005951 |
| 135 | Lysine degradation_Homo sapiens_hsa00310 | 0.21777566 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.20401146 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20189304 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.20079961 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18846601 |

